May 05, 2025
Articles by
-
Hugh Rogers on the European approval of the XPhyto Therapeutics point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system
In a recent InvestorIntel interview, Peter Clausi spoke with Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp. (CSE:…
-
Sixth Wave Innovations Dr Jon Gluckman on the colorimetric detection of SARS-CoV-2
In a recent InvestorIntel interview, Tracy Weslosky spoke with Dr. Jon Gluckman, President, CEO and Founder of Sixth…
-
StageZero’s New Cancer-Testing Platform and Health Clinics Acquisition Forms Telemedicine “Circle of Care”
StageZero Life Sciences Ltd. (TSX: SZLS) is a life science and telehealth company that recently launched Aristotle®, which…
-
ZEN Graphene proves product superiority of face masks and investors respond.
Despite a recent setback in perception ZEN Graphene Solutions Ltd. (TSXV: ZEN) continues to power ahead with the…
-
Valeo Pharma launches Redesca™ and is forecasting company revenues to increase 20x by 2025
Bringing new pharmaceutical products to market is a long and expensive process. One Canadian company has found an…
